HCPLive Five: Pulmonology Updates at ATS 2026

The 2026 American Thoracic Society (ATS) International Conference in Orlando, Florida, from May 15 – 20, delivered a wave of late-breaking clinical data across pulmonology, sleep medicine, and respiratory infectious disease. In this HCPLive Five, 5 leading physician experts break down the findings clinicians need to know, from the first oral pharmacotherapy for obstructive sleep apnea (OSA) nearing US Food & Drug Administration (FDA) approval to a 55% risk reduction in pulmonary arterial hypertension (PAH) to new frontiers in Mycobacterium avium complex lung disease (MACLD), tuberculosis (TB), and chronic obstructive pulmonary disease (COPD) biologic therapy.